Clinical trial
Is Greater Downstaging and Tumour Regression Observed When Surgery is Delayed to 12 Weeks After Completion of Chemoradiotherapy vs 6 Weeks?
NCT01037049 is registered in ClinicalTrials.gov with Royal Marsden NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Is Greater Downstaging and Tumour Regression Observed When Surgery is Delayed to 12 Weeks After Completion of Chemoradiotherapy vs 6 Weeks?
- Lead sponsor
- Royal Marsden NHS Foundation Trust
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- October 16, 2009
- Completion date
- December 8, 2019
- Enrollment
- 237 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.
adenocarcinoma, adenocarcinoma of the rectum, adenocarcinoma, mucinous, carcinoma, colorectal neoplasms, digestive system diseases, digestive system neoplasms, gastrointestinal diseases, gastrointestinal neoplasms, intestinal diseases, intestinal neoplasms, neoplasms, neoplasms by histologic type, neoplasms by site, neoplasms, cystic, mucinous, and serous, neoplasms, glandular and epithelial, rectal diseases